Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN
 

_____ Brought to you by Thermo Fisher Scientific _____

How drug repurposing can accelerate the search for new treatments

REGISTER NOW

 

  September 2, 2020

  8:00 a.m. PDT, 11:00 a.m. EDT, 16:00 BST, 17:00 CEST

 

Overview

 

Despite advances in technology and our understanding of biology, bringing a new drug to market is now taking longer and is becoming slower and increasingly expensive. One potential solution gaining traction within the industry is drug repurposing: harnessing existing medicines for new therapeutic applications. Recently this strategy has made headlines around the world as scientists attempt to repurpose existing drugs to fast track the discovery of treatments for COVID-19.

Brought to you by:

 

Key Learning Objectives

  • The challenges facing drug discovery scientists today
  • How repurposing existing drugs to new therapies can accelerate the search for new treatments
  • How bioactive molecules, such as antivirals, can be used to aid discovery of new drugs

Who Should Attend

  • Drug discovery scientists
  • Medicinal chemists
  • Synthetic organic chemists
 

Speaker

Simon Pearce
Senior Product Manager,
Laboratory Chemicals,
Thermo Fisher Scientific
 

Moderator

Catherine Dold
Health & Environment Writer,
C&EN Media Group
 

REGISTER NOW